Title |
Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician’s perspective
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, July 2020
|
DOI | 10.1186/s40545-020-00249-9 |
Pubmed ID | |
Authors |
A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel, C. J. J. Mulder |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 80% |
Pakistan | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 2 | 40% |
Members of the public | 2 | 40% |
Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 162 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 26 | 16% |
Researcher | 19 | 12% |
Student > Master | 18 | 11% |
Other | 11 | 7% |
Student > Doctoral Student | 8 | 5% |
Other | 27 | 17% |
Unknown | 53 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 43 | 27% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 9% |
Agricultural and Biological Sciences | 10 | 6% |
Nursing and Health Professions | 8 | 5% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Other | 19 | 12% |
Unknown | 62 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2020.
All research outputs
#7,299,408
of 23,221,875 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#178
of 418 outputs
Outputs of similar age
#142,953
of 366,195 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#13
of 26 outputs
Altmetric has tracked 23,221,875 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 418 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,195 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.